Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2006; 12(45): 7250-7262
Published online Dec 7, 2006. doi: 10.3748/wjg.v12.i45.7250
Published online Dec 7, 2006. doi: 10.3748/wjg.v12.i45.7250
Parameters | Values | |||
Controls (mean1± SE) | Patients with PBC (mean2± SE) | mean1/ mean2 | ||
Bile acids (g/L) | Bile | 3.9 ± 0.8 | 0.65 ± 0.02 | 6.0 |
Blood | 0.012 ± 0.008 | 0.054 ± 0.008 | -0.2 | |
Cholesterol (μmol/L) | Bile | 0.91 ± 0.06 | 0.38 ± 0.08 | 2.4 |
Blood | 4.2 ± 0.6 | 11.8 ± 1.6 | -0.4 | |
Lecithina | Bile | 2.1 ± 0.3 | 0.5 ± 0.1 | -4.6 |
Orthophosphatea | Bile | 1.2 ± 0.3 | 0.30 ± 0.07 | 4.0 |
Liver lesion | Cd (mean ± SD) | Cd ranges |
PBC (n = 11) | 0.61 ± 0.03b | 0.41 ± 0.84 |
CH (n = 20) | 0.14 ± 0.04 | 0.02-0.24 |
LC (n = 3) | 0.18 ± 0.03 | 0.14-0.24 |
UH (n = 8) | 0.11 ± 0.02 | 0.00-0.16 |
FH (n = 11) | 0.07 ± 0.02 | 0.00-0.14 |
Controls (n = 16) | 0.09 ± 0.02 | 0.00-0.18 |
- Citation: Reshetnyak VI. Concept on the pathogenesis and treatment of primary biliary cirrhosis. World J Gastroenterol 2006; 12(45): 7250-7262
- URL: https://www.wjgnet.com/1007-9327/full/v12/i45/7250.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i45.7250